“…Seroprevalence studies demonstrate that human populations are exposed to TOSV in Italy, Spain, France, Portugal, Turkey, Malta, Cyprus, Greece, Croatia, Bosnia and Herzegovina, Kosovo, Bulgaria, Tunisia, and Algeria [7,[22][23][24][25][26][27][28][29][30][31][32][33][34][35][36]. Together, the results of serological surveillance studies and case reports showed that the TOSV geographic distribution is much wider than believed a decade ago; in particular, the presence of TOSV has been recently documented in North Africa and the Balkan countries [31,32,[34][35][36] (Figure 2).…”